|
US5372823A
(en)
*
|
1989-03-16 |
1994-12-13 |
Bristol-Myers Squibb Company |
Direct compression cholestyramine tablet and solvent-free coating thereof
|
|
US6482516B1
(en)
*
|
1993-07-20 |
2002-11-19 |
Banner Pharmacaps, Inc. |
Enrobed tablet
|
|
IE61651B1
(en)
*
|
1990-07-04 |
1994-11-16 |
Zambon Spa |
Programmed release oral solid pharmaceutical dosage form
|
|
US5571533A
(en)
*
|
1992-02-07 |
1996-11-05 |
Recordati, S.A., Chemical And Pharmaceutical Company |
Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
|
|
AU3949093A
(en)
*
|
1992-03-31 |
1993-11-08 |
Benzon Pharma A/S |
A pharmaceutical formulation
|
|
GB2267219B
(en)
*
|
1992-05-28 |
1996-04-03 |
Elan Corp Plc |
Differential release tablet with multiple active agents
|
|
US5500227A
(en)
*
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
|
US6210714B1
(en)
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
|
GB9325445D0
(en)
|
1993-12-13 |
1994-02-16 |
Cortecs Ltd |
Pharmaceutical formulations
|
|
FR2717388B1
(fr)
*
|
1994-03-21 |
1996-11-22 |
Synthelabo |
Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
|
|
FR2723536A1
(fr)
*
|
1994-08-11 |
1996-02-16 |
Seth Pawan |
Composition permettant une liberation selective d'un principe actif
|
|
EP0742008A1
(en)
*
|
1995-05-11 |
1996-11-13 |
Euro-Celtique S.A. |
Controlled release pharmaceutical formulations
|
|
US5773031A
(en)
*
|
1996-02-27 |
1998-06-30 |
L. Perrigo Company |
Acetaminophen sustained-release formulation
|
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
|
ATE380235T1
(de)
*
|
1996-12-06 |
2007-12-15 |
Procter & Gamble |
Beschichtetes reinigungsmittel in tablettenform
|
|
AU5775398A
(en)
*
|
1996-12-17 |
1998-07-15 |
Poli Industria Chimica S.P.A. |
Site-specific controlled release dosage formulation for mesalamine
|
|
US5914134A
(en)
*
|
1997-01-27 |
1999-06-22 |
Wockhardt Europe Limited |
Process for the pulsatile delivery of diltiazem HCL and product produced thereby
|
|
NL1005948C2
(nl)
*
|
1997-05-01 |
1998-11-09 |
Inst Voor Agrotech Onderzoek |
Omhulde stof met gecontroleerde afgifte.
|
|
NL1007696C1
(nl)
*
|
1997-05-01 |
1998-11-03 |
Inst Voor Agrotech Onderzoek |
Omhulde stof met gecontroleerde afgifte.
|
|
ZA984591B
(en)
*
|
1997-06-09 |
1998-12-08 |
Ambi Inc |
A method for the treatment of diarrheal disease and for elmininating particular bacterial populations from the colon
|
|
US20060116330A1
(en)
*
|
1997-07-08 |
2006-06-01 |
The Iams Company |
Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
|
|
US8563522B2
(en)
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
|
US20020035071A1
(en)
*
|
1997-07-08 |
2002-03-21 |
Josef Pitha |
Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
|
|
NZ503086A
(en)
|
1997-08-29 |
2002-03-01 |
Upjohn Co |
An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
|
|
ES2157731B1
(es)
*
|
1998-07-21 |
2002-05-01 |
Liconsa Liberacion Controlada |
Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
|
|
US6638534B1
(en)
*
|
1998-07-28 |
2003-10-28 |
Tanabe Seiyaku Co., Ltd. |
Preparation capable of releasing drug at target site in intestine
|
|
US20070122481A1
(en)
*
|
1998-11-02 |
2007-05-31 |
Elan Corporation Plc |
Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer
|
|
US20090149479A1
(en)
*
|
1998-11-02 |
2009-06-11 |
Elan Pharma International Limited |
Dosing regimen
|
|
US20060240105A1
(en)
*
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
|
US20090297597A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Gary Liversidge |
Modified Release Ticlopidine Compositions
|
|
CN100444830C
(zh)
|
1998-11-02 |
2008-12-24 |
伊兰公司，Plc |
多颗粒改进释放组合物
|
|
EP1005863A1
(en)
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
|
US20030170181A1
(en)
*
|
1999-04-06 |
2003-09-11 |
Midha Kamal K. |
Method for preventing abuse of methylphenidate
|
|
EP1191924A4
(en)
|
1999-04-06 |
2005-02-09 |
Pharmaquest Ltd |
PHARMACEUTICAL DOSAGE FORM FOR INTERMITTENT ADMINISTRATION OF (D-THREO) -METHYLPHENIDATE AND A SECOND STIMULANT OF THE CENTRAL NERVOUS SYSTEM
|
|
CN1365275A
(zh)
*
|
1999-06-07 |
2002-08-21 |
南诺斯菲尔股份有限公司 |
包被颗粒的方法以及所得颗粒
|
|
ITMI991316A1
(it)
*
|
1999-06-14 |
2000-12-14 |
Cip Ninety Two 92 S A |
Composizioni farmaceutiche orali a rilascio modificato di mesalazina
|
|
EP1064937A1
(en)
*
|
1999-06-28 |
2001-01-03 |
Sanofi-Synthelabo |
Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
|
RU2230556C2
(ru)
|
1999-10-29 |
2004-06-20 |
Эро-Селтик, С.А. |
Препаративные формы гидрокодона с контролируемым высвобождением
|
|
WO2001054671A1
(fr)
*
|
2000-01-27 |
2001-08-02 |
Tanabe Seiyaku Co., Ltd. |
Preparation a liberation prolongee et son procede de fabrication
|
|
HUP0300491A2
(en)
*
|
2000-02-28 |
2003-07-28 |
Vectura Ltd |
Improvements in or relating to the delivery of oral drugs
|
|
WO2001064191A1
(de)
*
|
2000-02-28 |
2001-09-07 |
Akzo Nobel N.V. |
Körper für die kontrollierte abgabe von wirkstoffen
|
|
DE10012199A1
(de)
*
|
2000-03-13 |
2001-09-20 |
Haarmann & Reimer Gmbh |
Eingekapselte Substanzen mit kontrollierter Freisetzung
|
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
|
ATE401095T1
(de)
*
|
2000-05-26 |
2008-08-15 |
Frohwitter Bernhard |
Mittel zum erhalten und/oder korrigieren der blutglukosekonzentration
|
|
ES2185452B2
(es)
*
|
2000-08-01 |
2004-03-16 |
Cinfa S A Lab |
Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
|
|
HU230875B1
(hu)
|
2000-10-30 |
2018-11-29 |
Euro-Celtique S.A. |
Szabályozott hatóanyag-leadású hidrokodon készítmények
|
|
IL157634A0
(en)
*
|
2001-03-13 |
2004-03-28 |
Penwest Pharmaceuticals Co |
Chronotherapeutic dosage forms containing glucocorticosteroid
|
|
US8218183B2
(en)
*
|
2001-07-31 |
2012-07-10 |
Transpacific Systems, Llc |
Scanning speed control device and method
|
|
US7248387B2
(en)
|
2001-07-31 |
2007-07-24 |
Umax Data Systems, Inc. |
Scanning speed control device and method
|
|
US6500454B1
(en)
|
2001-10-04 |
2002-12-31 |
Eurand Pharmaceuticals Ltd. |
Timed, sustained release systems for propranolol
|
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
|
JP4031232B2
(ja)
*
|
2001-11-09 |
2008-01-09 |
カプスゲル・ジャパン株式会社 |
新規カプセル
|
|
US9308220B2
(en)
|
2001-12-11 |
2016-04-12 |
Cosmo Technologies Limited |
Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
|
|
ITMI20012599A1
(it)
*
|
2001-12-11 |
2003-06-11 |
Cosmo Spa |
Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
|
|
US20050025824A1
(en)
*
|
2001-12-14 |
2005-02-03 |
Eurand Pharmaceuticals Ltd. |
Pulsatile release histamine H2 antagonist dosage form
|
|
US6663888B2
(en)
*
|
2001-12-14 |
2003-12-16 |
Eurand Pharmaceuticals Ltd. |
Pulsatile release histamine H2 antagonist dosage form
|
|
DE60222803T2
(de)
*
|
2001-12-21 |
2008-07-17 |
Supernus Pharmaceuticals, Inc. |
Orale kapselformulierung mit verbesserter physikalischer stabilität
|
|
US7125563B2
(en)
*
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
|
US8168170B2
(en)
*
|
2002-10-03 |
2012-05-01 |
The Procter And Gamble Company |
Compositions having an inner core and at least three surrounding layers
|
|
US20080220074A1
(en)
*
|
2002-10-04 |
2008-09-11 |
Elan Corporation Plc |
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
|
|
RU2221559C1
(ru)
*
|
2002-11-15 |
2004-01-20 |
Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" |
Препарат диклофенак натрия длительного действия
|
|
US8367111B2
(en)
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
|
JP4790597B2
(ja)
|
2003-04-24 |
2011-10-12 |
ヤゴテック アーゲー |
規定されたコア幾何学的配置を有する遅延放出錠
|
|
WO2005027878A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Penwest Pharmaceuticals Co. |
Delayed released dosage forms
|
|
AU2004273958A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
|
US20050152884A1
(en)
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
|
US8894991B2
(en)
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
RU2267318C1
(ru)
*
|
2004-05-25 |
2006-01-10 |
Закрытое акционерное общество "ФАРМАПЭК" |
Пролонгированный антиангинальный препарат изосорбида динитрата и способ его получения
|
|
ITMI20041295A1
(it)
|
2004-06-25 |
2004-09-25 |
Cosmo Spa |
Composizioni farmaceutiche antimicrobiche orali
|
|
US8747895B2
(en)
*
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
|
ES2409347T3
(es)
|
2004-10-21 |
2013-06-26 |
Aptalis Pharmatech, Inc. |
Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles
|
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
|
JP4916163B2
(ja)
*
|
2004-12-01 |
2012-04-11 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
カプセル用コーティング剤
|
|
WO2006063078A2
(en)
*
|
2004-12-08 |
2006-06-15 |
Elan Corporation, Plc |
Topiramate pharmaceuticals composition
|
|
US20070298098A1
(en)
*
|
2005-02-16 |
2007-12-27 |
Elan Pharma International Limited |
Controlled Release Compositions Comprising Levetiracetam
|
|
KR20080007586A
(ko)
*
|
2005-04-12 |
2008-01-22 |
엘란 파마 인터내셔널 리미티드 |
세균감염증의 치료를 위한 세팔로스포린 함유 조절 방출조성물
|
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
|
US20060280788A1
(en)
*
|
2005-05-09 |
2006-12-14 |
Casey Stephen M |
Delivery and formulations of mast cell stabilizers
|
|
AU2006253007B2
(en)
|
2005-05-31 |
2012-12-20 |
Alimentary Health Ltd |
Feline probiotic Bifidobacteria
|
|
CA2609617C
(en)
|
2005-05-31 |
2014-07-08 |
The Iams Company |
Feline probiotic lactobacilli
|
|
WO2007037790A2
(en)
*
|
2005-06-08 |
2007-04-05 |
Elan Corporation, Plc |
Modified release famciclovir compositions
|
|
US20070020333A1
(en)
*
|
2005-07-20 |
2007-01-25 |
Chin-Chih Chiang |
Controlled release of hypnotic agents
|
|
EP1909769A2
(en)
*
|
2005-08-01 |
2008-04-16 |
Alpharma, Inc. |
Alcohol resistant pharmaceutical formulations
|
|
US20070036859A1
(en)
*
|
2005-08-11 |
2007-02-15 |
Perry Ronald L |
Sustained release antihistamine and decongestant composition
|
|
WO2007065559A1
(en)
|
2005-11-18 |
2007-06-14 |
Synthon B.V. |
Zolpidem tablets
|
|
EP2049123B2
(en)
|
2006-08-03 |
2016-08-24 |
Horizon Pharma AG |
Delayed-release glucocorticoid treatment of rheumatoid disease
|
|
RU2436581C2
(ru)
|
2007-02-01 |
2011-12-20 |
Дзе Иамс Компани |
Способ уменьшения воспаления и снижения стресса у млекопитающего
|
|
US8486452B2
(en)
*
|
2007-07-20 |
2013-07-16 |
Mylan Pharmaceuticals Inc. |
Stabilized tolterodine tartrate formulations
|
|
US8110226B2
(en)
*
|
2007-07-20 |
2012-02-07 |
Mylan Pharmaceuticals Inc. |
Drug formulations having inert sealed cores
|
|
US20090036414A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
|
FR2920431B1
(fr)
|
2007-08-29 |
2010-03-12 |
Essilor Int |
Procede de preparation d'un materiau transparent de type alliage de polymere thermodurcissable/polymere thermoplastique et son application dans l'optique pour la fabrication de verres organiques.
|
|
FR2920337B1
(fr)
|
2007-08-29 |
2010-03-12 |
Essilor Int |
Procede de preparation d'un article moule transparent a base d'un alliage de polymere thermoplastique et de polymere thermodurcissable
|
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
|
CN102958515A
(zh)
|
2009-12-02 |
2013-03-06 |
阿普塔利斯制药有限公司 |
非索非那定微胶囊及含有非索非那定微胶囊的组合物
|
|
US20150164920A1
(en)
|
2012-03-30 |
2015-06-18 |
Laboratorios Del Dr. Esteve S.A. |
Controlled release formulation comprising mesalamine
|
|
CA2936740C
(en)
|
2014-10-31 |
2017-10-10 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
|
GB201420306D0
(en)
|
2014-11-14 |
2014-12-31 |
Bio Images Drug Delivery Ltd |
Compositions
|
|
GB201420300D0
(en)
|
2014-11-14 |
2014-12-31 |
Bio Images Drug Delivery Ltd |
Tablet
|
|
GB201420311D0
(en)
*
|
2014-11-14 |
2014-12-31 |
Bio Images Drug Delivery Ltd |
Pharmaceutical processing
|
|
WO2016174664A1
(en)
|
2015-04-29 |
2016-11-03 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
|
US11504327B1
(en)
|
2019-01-21 |
2022-11-22 |
Eric Morrison |
Method of preparing nanoparticles by hot-melt extrusion
|
|
EP4622671A1
(en)
*
|
2022-11-21 |
2025-10-01 |
Eric Morrison |
Nanoparticle dispersions comprising therapeutic agents
|